Table 3.
Measures | NTG (n = 10) | HTG (n = 10) | η2 (p) Value | ||||||
---|---|---|---|---|---|---|---|---|---|
Before | After | Mean Change (95% CI) |
Before | After | Mean Change (95% CI) |
Time | Group | Interaction | |
RBC (×106/µL) | 4.70 ± 0.49 | 4.57 ± 0.50 | −0.14 * (−0.22, −0.05) |
5.16 ± 0.44 | 4.84 ± 0.43 | −0.32 * (−0.39, −0.24) |
0.820 (0.000) † |
0.144 (0.099) |
0.417 (0.002) † |
Hb (g/dL) | 14.79 ± 1.43 | 14.41 ± 1.46 | −0.38 * (−0.60, −0.15) |
15.51 ± 1.21 | 14.64 ± 1.31 | −0.87 * (−1.11, −0.63) |
0.806 (0.000) † |
0.033 (0.813) |
0.397 (0.003)† |
Hct (%) | 44.35 ± 3.41 | 43.95 ± 3.73 | −0.40 (−1.29, 0.49) |
46.40 ± 3.19 | 43.99 ± 3.46 | −2.41 * (−3.12, −1.70) |
0.642 (0.000) † |
0.025 (0.502) |
0.479 (0.001)† |
EPO (mU/mL) | 9.11 ± 2.22 | 10.16 ± 3.47 | 2.30 (0.87, 3.72) |
10.16 ± 3.47 | 15.25 ± 2.00 | 5.09 (2.16, 8.01) |
0.593 (0.000) † |
0.271 (0.019)† |
0.173 (0.068) |
MCV (μm2) | 94.58 ± 3.52 | 96.54 ± 3.40 | 1.95 (1.59, 2.31) |
90.15 ± 2.90 | 91.03 ± 2.16 | 0.88 (−0.73, 2.49) |
0.456 (0.001) † |
0.444 (0.001)† |
0.107 (0.159) |
MCH (μg) | 31.49 ± 1.17 | 31.61 ± 1.04 | 0.12 (−0.11, 0.36) |
30.14 ± 1.32 | 30.29 ± 1.30 | 0.16 (−0.14, 0.46) |
0.135 (0.111) |
0.258 (0.022) † |
0.003 (0.823) |
MCHC (g/dL) | 33.30 ± 0.84 | 32.75 ± 0.63 | −0.55 (−0.84, −0.26) |
33.42 ± 0.91 | 33.27 ± 0.96 | −0.15 (−0.63, 0.33) |
0.310 (0.011) † |
0.042 (0.395) |
0.128 (0.122) |
Values are expressed as means ± standard deviations. CI, confidence interval; EPO, erythropoietin; Hb, hemoglobin; Hct, hematocrit; HTG, hypoxic training group; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; NTG, normoxic training group; RBC, red blood cells. Significant interaction or main effect: † p < 0.05; Significant difference before and after training: * p < 0.05.